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Abstract
Previous experiments indicated that secreted (s) and membrane (m) forms of folate binding protein (FBP) are present in the
intrauterine environment of the pig. Our previous studies indicated that the two forms were produced sequentially; the secreted form
was present in the intrauterine glands until Day 20 of gestation, whereas binding analysis indicated that folate binding increased
dramatically in placental membranes until Day 50 of gestation. However, the cell types expressing mFBP have not been
investigated. In this experiment, uterine wall sections from Day 20, 35, 50, 70, 90, and 105 of gestation were collected at slaughter
and fixed, and subjected to in situ hybridization analysis for mFBP expression. The mFBP mRNAwas expressed by both columnar
and cuboidal epithelia of the placental folds and expression appeared to be similar throughout gestation. Therefore, the placenta
expressed mFBP from Day 35 of gestation onward, consistent with the concept that sFBP and mFBP occur sequentially during
gestation in swine, and that placental mFBP expression plays a role in folate transport after a functional chorioallantoic placenta is
established (between Day 20 and 35).
Published by Elsevier Inc.
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1. Introduction
Folate is required as a cofactor in the transfer of
methyl groups, i.e. biochemical reactions which include
thymidine synthesis [1]. Thus, folate is essential for cell
division and growth [2], and deficiencies impair
processes, e.g. erythropoiesis [3] and fetal development
[4] where rapid cell division occurs. Secreted (s) and
membrane (m) forms of folate binding protein (FBP)
were present in the intrauterine environment of the pig
to deliver folate to the developing fetuses [5–9]. In more
recent studies, it was reported that the two forms were
produced sequentially during the 114-d gestation of the
pig. The sFBP form increased dramatically in uterine
flushings at the time of conceptus elongation (Day 11–
15) and was present in the intrauterine glands until Day
20 of gestation [7,10]. We have demonstrated that
genetic polymorphisms in the sFBP gene were
associated with differences in uterine capacity, but
not litter size, because of simultaneous effects on
ovulation rate [11]. Thus, other genes involved in folate
transport during gestation are of interest as potential
candidate genes for genetic markers associated with
uterine capacity and litter size. Placental membrane
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folate binding increased dramatically until Day 50 of
gestation [10]. However, two membrane forms of FBP
are known in swine, one intrauterine [8] and one
isolated from the liver [12], thus, we could not
determine whether the intrauterine form of mFBP
previously described [8] contributed to placental
membrane folate binding during pregnancy. The
measurement of folate binding reported previously
did not distinguish between the two membrane forms.
Further associations between variation in the genes
responsible for folate transport and uterine capacity and
litter size require the identification of the genes involved
in folate transport during pregnancy. In addition,
placental cell types expressing mFBP have not been
investigated. Identification of the cell types responsible
are needed to fully understand the role of various tissues
in folate transport during pregnancy. Thus, our objective
was to confirm that the intrauterine membrane form of
FBP that we described previously was expressed during
pregnancy and to determine the cells expressing mFBP
in the uterus and placenta throughout gestation.
2. Materials and methods
Unless otherwise indicated, all chemicals used were
purchased from Sigma–Aldrich (St. Louis, MO, USA).
All gilts in this experiment were fed a standard swine
diet that met the NRC recommendations for folate.
Estrus detection was performed using intact boars
beginning at approximately 200 d of age. White
composite gilts were mated at standing estrus (Day
0) or remained not pregnant. Gilts were slaughtered on
Day 10, 13 and 15 of the estrous cycle (n = 4, 3, 3,
respectively) or pregnancy (n = 3, 3, 6, respectively),
and on Day 20 (n = 3), 35 (n = 4), 50 (n = 5), 70 (n = 3),
90 (n = 5), and 105 (n = 3) of pregnancy. For gilts killed
from Day 10 to 15 of the cycle or pregnancy, the uterus
was flushed with 20 mL Minimal Essential Medium to
collect uterine flushings and confirm pregnancy.
Pregnancy was confirmed by the presence of conceptus
tissue of normal appearance. For all gilts, a section of
uterine wall was collected and fixed with 4%
paraformaldehyde in PBS. After 16 h, fixed tissues
were washed with PBS (2  1 h), dehydrated through a
graded series of ethanol concentrations followed by
three changes of xylene, incubated in two changes of
paraffin (60 8C), and were embedded in paraffin [10]. In
situ hybridization was performed essentially as
described by Spencer et al. [13]. Sections were cut
(6 mm), placed on slides, deparaffinized in xylene, and
then rehydrated to water through a graded series of
ethanol concentrations. Slides were then incubated with
Proteinase K (20 mg/mL) for 8 min at 37 8C, rinsed
twice for 5 min each in PBS, and then hybridization
solution containing radiolabeled cRNA probes
(5  106 cpm/slide) was applied to each slide and
coverslipped. The mFBP probe used was based on the
previously reported intrauterine mFBP cDNA sequence
[8]. A 117-bp fragment of the 30 end of the mFBP cDNA
that was 35% identical to the same region of the sFBP
cDNA, 47% identical to porcine liver mFBP [12] and
that was previously shown to distinguish between sFBP
and intrauterine mFBP cDNAs [8], was used as
template to synthesize cRNA probes. Tissue specificity
of the mFBP probe was reported previously; this probe
did not hybridize to RNA from pig liver [8], clearly
indicating that it did not cross-hybridize with the pig
liver form of mFBP. Antisense and sense cRNA probes
were generated using T7 and SP6 RNA polymerases
(Maxiscript RNA synthesis kit, Ambion, Austin, TX,
USA), respectively, from a linearized porcine mFBP
plasmid template in the presence of 35S-labeled UTP
(specific activity, 3000 Ci/mmol; GE Healthcare,
Piscataway, NJ, USA). Slides were incubated in a
humidified chamber and hybridized overnight at 55 8C.
Slides were washed and incubated with DNase-free
RNase (10 mg/mL). Sections were dehydrated through a
graded series of ethanol and xylene, dried, and dipped in
Kodak NTB2 emulsion (Eastman Kodak, Rochester,
NY, USA). Slides were allowed to dry and were then
exposed for 2 weeks, developed, and counterstained
with Harris’ modified hematoxylin in acetic acid
(Fisher, Fairlawn, NJ, USA). Slides were visually
appraised for specific labeling by comparison of silver
grain density of antisense and sense probe labeled
slides. Because in situ hybridization is not quantitative,
particularly when probes labeled in different reactions
are used as they were here, no attempt was made to
quantify silver grain densities. Within each batch of
slides, tissue sections from Day 35 of pregnancy or later
were included to ensure that hybridizations were
successful (these served as positive controls for the
in situ hybridization technique; in each batch, specific
labeling above the placental epithelium was evident).
3. Results
No convincing evidence of specific labeling for
mFBP mRNA was observed in endometrial stromal
cells and endometrial epithelia during the estrous cycle
or pregnancy (Figs. 1 and 2) in any gilts examined in
this experiment. In contrast, mFBP mRNA was
expressed by chorionic epithelia (Fig. 3a), including
both columnar and cuboidal forms in all gilts examined
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between Day 35 and 105 of gestation (Fig. 4). Although
the in situ hybridizations presented here were not
quantitative due to hybridization with different probe
batches, expression was consistently evident in all
placentae from Day 35 to 105.
4. Discussion
In situ hybridization analysis indicated that mFBP
was expressed primarily in the chorionic epithelia from
Day 20 of gestation onward. No convincing evidence of
specific labeling for the intrauterine form of mFBP was
obtained for any endometrial cell type during the
estrous cycle or pregnancy. These results were
consistent with our previous findings that placental
folate binding was present from Day 35 of pregnancy
[10] and that mFBP mRNAwas present in the placenta
on Day 30 of pregnancy, as measured by Northern blot
analysis [8]. However, results of the present study were
not consistent with those from previous experiments
that indicated that mFBP mRNA was expressed by the
endometrium during the estrous cycle and early
pregnancy [8].
The lack of homology between the region of the
mFBP cDNA used as probe compared to the other
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Fig. 1. Localization of expression of the membrane form of folate
binding protein (mFBP) during the estrous cycle and pregnancy in
endometrial glands in pigs. No differences were observed in the
abundance of silver grains over the endometrial glands between
antisense (AS) and sense (S) probes (sense probe hybridizations
not shown; see Figs. 2 and 3 for representative sense probe labeling).
Fig. 2. In situ hybridization analysis of a uterine wall section from
Day 50 of gestation in pigs for the membrane form of folate binding
protein (mFBP) using antisense and sense probes. An area including
the endometrial glands is shown using both dark and bright-field
microscopy. No specific labeling above the endometrial gland cells
was observed in the antisense probe compared to the sense-treated
slides.
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Fig. 4. In situ hybridization analyses for the membrane form of folate
binding protein (mFBP) of uterine wall sections collected throughout
gestation in pigs. Silver grains were more abundant over the placental
epithelium, including both the tall columnar epithelium at the top of
placental folds and the cuboidal epithelium present in the sides and
bottom of placental folds. Although in situ analysis is not quantitative,
the strength of labeling over the placental epithelium appeared to be
uniform throughout gestation from Day 20 to 105.
Fig. 3. In situ hybridization analysis of a uterine wall section from
Day 50 of gestation in pigs for the membrane form of folate binding
protein (mFBP) using antisense (a) and sense probes (b). An area
including the placental and endometrial epithelium is shown using
both dark and bright-field microscopy. More abundant silver grains
were clearly and uniformly evident over the trophoblast epithelium
(TE) compared to endometrial epithelium (EE) when sections were
incubated with antisense compared with sense probe.
known forms of FBP, combined with differential
patterns of expression of the different forms in various
tissues [8,12], indicated that cross-hybridization of our
mFBP probe with related forms of folate binding
proteins did not occur. Our previous sFBP immuno-
histochemistry results clearly indicated the presence of
sFBP up to Day 20 of pregnancy in the endometrial
glands [10] and radioimmunoassay measurements and
western blotting both indicated a dramatic increase in
sFBP in uterine flushings [6,7]. This suggested the
hypothesis that mFBP provided folate to endometrial
gland cells for binding to the newly synthesized
secreted form, which would then be secreted into the
intrauterine environment. Thus, our failure to detect
mFBP mRNA in the endometrium of pigs during the
estrous cycle and pregnancy was surprising. Northern
analysis for mFBP reported previously provided very
light bands during the estrous cycle and pregnancy, with
a convincing band present only for Day 15 pregnant
endometrial tissue, and a very strong band from
endometrium on Day 30 of pregnancy [8]. The
discrepancy on Day 15 and 30 of pregnancy between
the current experiment compared to previous results
may be explained by contamination of endometrial
tissue with conceptus tissue in our previous study.
Superficial adhesion of conceptus tissue to the
endometrium begins on Day 13 of gestation; therefore,
endometrial tissue could remain contaminated with
conceptus tissues despite flushing (Day 15) and careful
dissection (Day 30) [14]. Another possibility that
explains the lack of specific labeling during the estrous
cycle and early pregnancy may be that the level of
expression of mFBPwas too low and too dispersed in the
endometrium during the estrous cycle and early
pregnancy to localize using our in situ hybridization
methods. Given that intrauterine mFBP cannot be
localized to the endometrial glands, an alternative
hypothesis might be that the liver form of mFBP [12],
which has never been examined in the intrauterine
environment, could deliver folate to the endometrial
glands. However, a further possibility is that the sFBP
that is present in uterine flushings and endometrial glands
is not a product of the glands themselves and instead
might originate from serum. Endometrial expression of
mRNA for sFBP does not change from Day 10 to 40 of
pregnancy [8], despite dramatic increases in sFBPprotein
in uterine flushings [6,7] and clear immunohistochemical
staining of endometrial glands for sFBP from Day 13 to
20 of pregnancy, which disappears by Day 35 [10]. We
have also been unable to demonstrate de novo production
of sFBP by endometrial explants in culture in the
presence of 35S-methionine (Kim and Vallet, unpub-
lished observations), further suggesting that the sFBP in
uterine flushings is not produced by endometrium. We
recently demonstrated that many serum proteins were
present in high concentrations in uterine flushings during
this period [15]. Unfortunately, comparison between
serumand uterine flush FBPdid not providemuch insight
into whether uterine flush FBP originated from serum.
Unlike uterine flush FBP, which is known to correspond
to the secreted form, we are unaware of a similar amino
acid sequence analysis of porcine serumFBP. SerumFBP
could originate from any of the known porcine forms of
FBP, as phospholipases are capable of liberating
membrane forms of FBP. Comparison of binding
affinities are not helpful because uterine flush [6,10],
porcine serum [16] and placental membrane [10] forms
of FBP all have approximately similar binding affinities
(Kd .1–.5 nM). In addition, the binding affinity of porcine
serum FBP changes depending on the surrounding lipid
environment [10], which is likely to differ substantially
between serumand the uterine lumen.The origin of sFBP
in uterine flushings is beyond the scope of these
experiments and requires further research.
We provided clear evidence that the intrauterine form
of mFBP was expressed by the pig placenta throughout
most of gestation, consistent with the previously
proposed concept that sFBP was secreted by uterine
glands until formation of the placenta and placental
mFBP expression took over folate transport during later
gestation in swine [10]. Therefore, expression of mFBP
was at least partially responsible for the placental cell
membrane folate binding measured in our previous
report. However, it did not preclude a contribution from
the other known form ofmFBP [12], which is beyond the
scope of this paper and will require further experimenta-
tion. Furthermore, basedon in situ hybridization analysis,
all placental epithelial cells expressed mFBP, including
the tall columnar cells at the apices and the cuboidal cells
on the sides and nadirs of the placental folds. Differences
in the morphology of these cells suggested different
functions. Friess et al. [17] suggested that the tall
columnar epithelial cells were specifically responsible
for the transfer of substrates from the dam to the fetus.
The observation that all the placental epithelial cells
expressed mFBP uniformly was not consistent with this
concept, although the tall columnar epithelial cells may
participate in the specific transfer of other substrates, in
addition to folate. The role of the placental tall columnar
epithelial cells in placental function requires further
investigation.
In conclusion, we demonstrated that the pig placenta
expressed the intrauterine form of mFBP throughout
most of gestation, consistent with a role for mFBP in
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folate transport after the development of the placenta
between Day 20 and 30 of pregnancy. We were unable
to demonstrate specific expression of mFBP mRNA in
endometrial cells at any stage of the cycle or pregnancy,
in contrast to previous results demonstrating endome-
trial expression of mFBP by Northern blotting. This
discrepancy was likely to be due to contamination of
endometrial tissue by conceptus tissue caused by
adhesion of conceptus tissue to the endometrial surface
during pregnancy.
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